Cystic Fibrosis Flashcards

1
Q

What is cystic fibrosis (CF)?

A
  • CF is an incurable, hereditary disease caused by a mutation in the gene for protein cystic fibrosis transmembrane conductance regulator (CFTR)
  • The average life expectancy is 35-40 years with most of the patients being diagnosed by 2 years of age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does the mutation of CF causes?

A
  • Abnormal transport of chloride, bicarbonate and sodium ions across the epithelium, leading to thick, viscous secretions
  • The thick mucus affects the lungs, pancreas, liver and intestines, which causes difficulty breathing, lung infections and digestive complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do you diagnose CF?

A
  • Newborn screening is performed in the first 2-3 days after a baby is born. If it identifies a risk of CF, then a sweat chloride test (“sweat test”) is performed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the signs and symptoms of CF?

A
  • Salty tasting skin
  • Poor growth
  • Poor weight gain
  • Mucus production
  • Frequent lung infections
  • Coughing and SOB
  • Steatorrhea (fatty stools)
  • Malnutritions (if CF is not treated)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do you reduce lung complications in CF?

A
  • Administering inhaled medications in the correct order is critical to maximize absorption and effect
  • Airway clearance therapies are given before inhaled antibiotics
  • Inhaled medications are delivered directly to the lungs, resulting in minimal systemic absorption (reducing the risk of toxicity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List the inhaled medications used to reduce the lung complications in order and their purpose

A
  1. Inhaled bronchodilators (e.g., albuterol) - Opens the airways
  2. Hypertonic saline (e.g., HyperSal) - Mobilizes mucus to improve airway clearance
  3. Dornase alfa (Pulmozyme) - Decreases viscosity of (thins) mucus to promote airway clearance
  4. Chest physiotherapy - Mobilizes mucus to improve airway clearance
  5. Inhaled antibiotics - Controls airway infection

Most patients will require oral medications (e.g., pancreatic enzyme products, azithromycin). These can be given at any time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which organisms cause intermittent infection?

A
  • Early in the disease: Staphylococcus aureus and Haemophilus influenzae
  • Adolescents and adults: Pseudomonas aeruginosa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is acute pulmonary exacerbations characterized?

A
  • Increase in cough, sputum production with a greenish sputum, SOB and decline in FEV1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What medications are recommended for infections caused by Pseudomonas aeruginosa? And why?

A
  • Two IV drugs are recommended to provide potential synergy and prevent resistance
  • These include aminoglycosides
  • Doses tend to be larger than normal to address altered pharmacokinetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is chronic infection treated in CF?

A
  • Inhaled antibiotics are recommended for patients with chronic Pseudomonas aeruginosa infections
  • Treatment is cycled with 28 days on therapy, followed by 28 days off
  • If a patient is using a bronchodilator and/or mucolytic, these should be given prior to the antibiotic inhalation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When to consider initiating azithromycin treatment? How does it work?

A
  • A 6 month azithromycin trial can be considered for patients with chronic infection who are worsening on conventional treatment
  • Azithromycin has no direct activity against Pseudomonas but it disrupts biofilm formation by the bacteria which can improve lung fx and decrease exacerbations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List airway clearance therapies and their drug effects

A

1) Bronchodilator (e.g., albuterol)

2) Hypertonic saline (HyperSal, PulmoSal)
* Delivered via a nebulizer

3) Dornase alpha (Pulmozyme)
* Decrease viscosity (thins) mucus
* Store ampules in the refrigerator
* Protect from light
* Do not mix with any other drug in the nebulizer

ALL INHALED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List inhaled antibiotics and their drug effects

A

Inhalation form to target Pseudomonas aeruginosa colonization to decrease infections/hospitalization

1) Tobramycin (TOBI, TOBI Podhaler)
* Solution for inhalation: all (except TOBI Podhaler) - 300 mg via nebulizer Q12H

  • Capsule for inhalation: TOBI Podhaler - 112 mg (4 x 28 mg caps) via inhalation Q12H
  • SEs: ototoxicity, tinnitus, voice alteration, mouth and throat pain
  • Give 28 days, followed by 28 days off
  • Doses must be 6 hours apart
  • TOBI, Bethkis, Kitabis: refrigeration recommended (can be kept at room temperature up to 28 days), do not mix with any other drug in the nebulizer
  • TOBI Podhaler: store capsules at room temperature, do not swallow capsules

2) Aztreonam and Azactam
* SEs: allergic reactions (maybe severe), bronchospasm, fever, wheezing, cough, chest discomfort

  • Give for 28 days, followed by 28 days off
  • Doses must be 4 hours apart
  • Refrigeration recommended (can be at room temperature up to 28 days)
  • Do not mix with any other drug in the nebulizer

ALL INHALED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Azithromycin is the only antibiotic taken __ to reduce __ and __.

Fill in the blank

A
  • Orally
  • Inflammation
  • Exacerbations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why most CF patients need to supplement their diets with pancreatic enzyme products (PEPs)?

A
  • The thick mucus in CF obstructs pancreatic enzyme flow, resulting malabsorption
  • PEPs are needed to help break down fat, starches and protein to help digest food, maintain weight and improve nutrient absorption. AKA pancreatic enzyme replacement therapy (PERT)
  • PEPs are formulated to dissolve in the more basic pH of the duodenum
  • The dose is individualized for each patient and is based on the lipase component
  • The dose is adjusted every 3-4 days until stools are normalized (no greasy, oily, foul-smelling)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is pancrelipase?

A
  • Natural product harvested from porcine pancreatic glands which contains combination of lipase, amylase and protease
17
Q

What are pancrelipase drug effects and its max dose?

A
  • Brand: Creon, Viokace, Zenpep
  • Max dose: <=10,000 units/kg/day
  • Warnings: colonic strictures, mucosal irritation
  • SEs: abdominal pain, flatulence, nausea
18
Q

What are common issues with PEPs?

A
  • Formulations are not interchangeable
  • Viokace is the only PEP that is a tablet. It is non-enteric coated so must be given with a PPI
  • All other PEPs are capsules
    - Do not crush or chew
    - DR capsules with enteric coat may be opened and sprinkled on soft, acidic foods (<=4.5) like applesauce. Avoid foods with high pH such as dairy
    - Do not retain the capsule contents in the mouth. Swallow immediately and follow with water to avoid mucosal irritation and stomatitis
  • Take PEPs before or with all meals and snacks. High fat meals may require higher doses; use 50% of the mealtime dose with snacks
  • Protect from moisture; dispense in original container (exceptions: Zenpep and some Creon strengths)
  • Do not refrigerate
19
Q

MOA of CF transmembrane conductance regulator modulators

A

Ivacaftor:
* Increases the time of the CFTR channels to remain open to enhance chloride transport activity

Lumacaftor, tezacaftor, elexacaftor:
* Help correct the CFTR folding defect to increase the amount of CFTR delivered to the cell surface

Notes:
* Genotype testing MUST be performed prior to initiation because each drug is approved for specific mutations

  • The most common mutation in the CFTR gene is a homozygous F508del mutation
  • CFTR modulators are taken with high-fat containing food
20
Q

Ivacaftor

Brand/generic, formulation, approved mutation

A
  • Brand: Kalydeco
  • Formulation: Tablet, oral granules
  • Not approved for use in the homozygous F508del mutation
21
Q

Homozygous F508del approved CFTR modulators

Brand/generic, formulation

A
  • Lumacaftor/ivacaftor (Orkambi): tablet, oral granules
  • Tezacaftor/ivacaftor (Symdeko): co-packaged tablets
  • Elaxacaftor/tezacaftor/ivacaftor (Trikafta): co-packaged tablets